Over-the-counter home conception kit proven efficacious

PITTSBURGH — A clinical study demonstrates that The Stork OTC is more effective at delivering sperm to the cervix than natural intercourse when trying to get pregnant. The peer-reviewed, post-coital sperm assessment study was performed over a 10-month period by study author Michael Pelekanos, and is published in the Surgical Technology International. 

 

The Stork OTC, the only FDA-cleared, over-the-counter home conception kit using cervical cap insemination, is clinically shown to deliver a higher concentration of sperm directly to the cervix compared to natural intercourse.

 

The study was an efficacy study designed to compare the number of sperm in the cervical mucus both with the use of The Stork OTC home conception kit and natural intercourse. Post-coital test data was collected after participants used both the Stork OTC home conception kit and the natural intercourse method to evaluate concentrations of sperm in the cervical mucus.

 

The results are promising for the one-in-six U.S. couples having difficulty conceiving with intercourse alone. “We were very excited to see the study results confirm that The Stork OTC delivers a significantly higher sperm concentration to the cervix,” said Stephen Bollinger, president and CEO of Rinovum Women’s Health. “With the new data demonstrating the efficacy of the Stork OTC in aiding conception compared to natural intercourse, couples trying to get pregnant now have a safe, clinically validated option to optimize their chances with the Stork OTC.”

 

In 85% of study subjects, the Stork OTC delivered a 3.23x higher value of sperm concentration at the cervix compared to the value of sperm concentration with natural intercourse.

 

The remaining 15% of study subjects saw no change in sperm concentration between The Stork OTC and natural intercourse.

 

The kit provides a way for the user to collect, insert and deliver the sperm directly at the opening of the cervix, and keeps it at the cervix for longer, giving sperm the opportunity to enter into the uterus. Considering most sperm never make it through the vaginal tract, the Stork OTC’s applicator provides a simple and safe way for the user to bypass the normally unfavorable vaginal environment, to deliver the sperm. Cervical cap insemination has documented success rates between 10% and 20%, similar to in-clinic intrauterine insemination success rates (16%-21%).